THE PEOPLE BEHIND THE PUBLICATIONS
Researchers & institutions Public profiles and publication affiliations help put the research in context. Inclusion here is a record of scholarly work, not a partnership, endorsement or hospital ranking.
Institution website ↗ Suzhou
The Second Affiliated Hospital of Soochow University Listed through authorship affiliations in the cited publication. Inclusion does not imply partnership with this website.
Case Report: PRaG 3.0 therapy for advanced cervical cancer with severe comorbidities ↗ Safety and efficacy of PRaG therapy in elderly cancer patients ↗ PRaG 5.0: Personalized thymosin alpha-1 and radioimmunotherapy for advanced refractory solid tumors—Data from an expanded cohort. ↗ All linked publications → Institution website ↗ Nanchong
Affiliated Hospital of North Sichuan Medical College Listed through authorship affiliations in the cited publication. Inclusion does not imply partnership with this website.
PRaG5.0 combined with chemotherapy and sequential chemoimmunotherapy for massive SMARCA4-deficient undifferentiated tumor of the cervix: case report ↗ All linked publications → Chengdu
Chengdu Fifth People’s Hospital Author affiliation documented in the linked original publication.
Case Report: PRaG 3.0 therapy for advanced cervical cancer with severe comorbidities ↗ All linked publications → Institution website ↗ Shanghai
Fudan University Shanghai Cancer Center The Shanghai cancer center led the independent SWORD multicenter trial, with a 20-patient safety run-in in 2021 and final results in 2024 (55 enrolled, 51 treated, 49 evaluable).
SWORD: final phase II results of sintilimab, SBRT and GM-CSF in metastatic NSCLC ↗ Sintilimab, stereotactic body radiotherapy and granulocyte-macrophage colony stimulating factor as second-line therapy for advanced non-small cell lung cancer: safety run-in results of a multicenter, single-arm, phase II trial ↗ All linked publications → Guiyang
Guizhou Provincial People's Hospital Listed through authorship affiliations in the cited publication. Inclusion does not imply partnership with this website.
Case Report: Multidisciplinary management of primary inferior vena cava leiomyosarcoma: a comprehensive case study ↗ All linked publications → Nanjing
Jiangsu Cancer Hospital Listed through authorship affiliations in the cited publication. Inclusion does not imply partnership with this website.
Hypofractionated radiotherapy combined with a PD-1 inhibitor, granulocyte macrophage-colony stimulating factor, and thymosin-α1 in advanced metastatic solid tumors: a multicenter Phase II clinical trial ↗ PD-1 inhibitor combined with SBRT, GM-CSF, and thymosin alpha-1 in metastatic breast cancer: A case report and literature review ↗ All linked publications → Jiangyin
Jiangyin Hospital Affiliated to Nantong University Author affiliation documented in the linked original publication.
Clinical efficacy of hypofractionated radiotherapy combined with immune checkpoint inhibitors in advanced metastatic solid tumors ↗ All linked publications → Wuxi
Jiangyuan Hospital Affiliated to Jiangsu Institute of Nuclear Medicine Listed through authorship affiliations in the cited publication. Inclusion does not imply partnership with this website.
Long-term survival in a patient with leptomeningeal metastases from non-small cell lung cancer treated with stereotactic radiotherapy (SRT), programmed cell death protein 1 (PD-1) inhibitor, and granulocyte-macrophage colony-stimulating factor (GM-CSF): a case report ↗ The Anti-tumor Effect and Immunological Cell Changes of PRaG Therapy in Colon Cancer Peritoneal Metastasis of Mice ↗ Study of effect of PRaG therapy in colon cancer transplanted tumor mouse model ↗ All linked publications → Beijing
Peking University Third Hospital Author affiliation documented in the linked original publication.
PD-1 Inhibitor and GM-CSF in Oligometastatic Gallbladder Adenosquamous Carcinoma: A Case Report ↗ All linked publications → Ningxia
People’s Hospital of Ningxia Hui Autonomous Region Listed through authorship affiliations in the cited publication. Inclusion does not imply partnership with this website.
Safety and efficacy of PRaG therapy in elderly cancer patients ↗ All linked publications → Wuhan
Renmin Hospital of Wuhan University Listed through authorship affiliations in the cited publication. Inclusion does not imply partnership with this website.
Anti-PD-1 Immunotherapy Combined With Stereotactic Body Radiation Therapy and GM-CSF as Salvage Therapy in a PD-L1-Positive Patient With Refractory Metastatic Thyroid Hürthle Cell Carcinoma: A Case Report and Literature Review ↗ All linked publications → Shanghai / Wuxi
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine (including Wuxi Branch) Listed through authorship affiliations in the cited publication. Inclusion does not imply partnership with this website.
Long-term survival in a patient with leptomeningeal metastases from non-small cell lung cancer treated with stereotactic radiotherapy (SRT), programmed cell death protein 1 (PD-1) inhibitor, and granulocyte-macrophage colony-stimulating factor (GM-CSF): a case report ↗ All linked publications → Institution website ↗ Taixing
Taixing People’s Hospital Affiliated to Yangzhou University Author affiliation documented in the linked original publication.
PRaG Therapy for Advanced Penile Squamous Cell Carcinoma with Abscopal Effects: A Case Report ↗ All linked publications → Institution website ↗ Luzhou
The Affiliated Hospital of Southwest Medical University Listed through authorship affiliations in the cited publication. Inclusion does not imply partnership with this website.
Case report: Interstitial implantation radiotherapy combined with immunotherapy and GM-CSF in oligometastatic platinum-resistant ovarian cancer ↗ All linked publications → Yixing
The Affiliated Yixing Clinical School of Medical School of Yangzhou University Listed through authorship affiliations in the cited publication. Inclusion does not imply partnership with this website.
Anti-PD-1 immunotherapy combined with stereotactic body radiation therapy and GM-CSF for the treatment of advanced malignant PEComa: A case report ↗ All linked publications → Suzhou
The Dushu Lake Affiliated Hospital of Soochow University Author affiliation documented in the linked original publication.
MRD-Guided PRaG 3.0 Therapy for HER-2 Positive Cervical Adenocarcinoma: A Case of Complete Remission ↗ The Anti-tumor Effect and Immunological Cell Changes of PRaG Therapy in Colon Cancer Peritoneal Metastasis of Mice ↗ Study of effect of PRaG therapy in colon cancer transplanted tumor mouse model ↗ All linked publications → Institution website ↗ Bengbu
The First Affiliated Hospital of Bengbu Medical University Listed through authorship affiliations in the cited publication. Inclusion does not imply partnership with this website.
Efficacy and immune characteristics of a PRaG-based regimen in advanced refractory solid tumors ↗ All linked publications → Institution website ↗ Nanning
The First Affiliated Hospital of Guangxi Medical University Listed through authorship affiliations in the cited publication. Inclusion does not imply partnership with this website.
Radiotherapy with PD-1 inhibition followed by GM-CSF and IL-2 in advanced malignancies: a clinical study ↗ Case Report: Pathologic complete response to PRaG therapy in an elderly patient with refractory metastatic gastric cancer ↗ All linked publications → Xi’an
The First Affiliated Hospital of Xi’an Jiaotong University Listed through authorship affiliations in the cited publication. Inclusion does not imply partnership with this website.
CXCR5+ monocyte emigration impairs the radiation-induced antitumor immune response ↗ Efficacy of PRaG therapy in microsatellite-stable metastatic colorectal cancer: a comparative analysis of PD-1/PD-L1 inhibitor-based combination therapies ↗ All linked publications → Suining
The First People's Hospital of Suining Listed through authorship affiliations in the cited publication. Inclusion does not imply partnership with this website.
Case report: Interstitial implantation radiotherapy combined with immunotherapy and GM-CSF in oligometastatic platinum-resistant ovarian cancer ↗ All linked publications → Institution website ↗ Chengdu
West China Hospital, Sichuan University Listed through authorship affiliations in the cited publication. Inclusion does not imply partnership with this website.
Case report: Interstitial implantation radiotherapy combined with immunotherapy and GM-CSF in oligometastatic platinum-resistant ovarian cancer ↗ All linked publications → Xi’an
Xi’an International Medical Center Hospital Listed through authorship affiliations in the cited publication. Inclusion does not imply partnership with this website.
Application of Immunoenhancing Radiotherapy in Treating Unresectable Intrahepatic Cholangiocarcinoma: A Case Report ↗ Combination treatment with anti-HER2 therapeutic antibody RC48, PD-1 inhibitor, radiotherapy, and granulocyte macrophage-colony stimulating factor (GM-CSF) in patient with metastatic gastric cancer: a case report ↗ All linked publications → Institution website ↗ Xuzhou
Xuzhou Cancer Hospital Listed through authorship affiliations in the cited publication. Inclusion does not imply partnership with this website.
Hypofractionated radiotherapy combined with a PD-1 inhibitor, granulocyte macrophage-colony stimulating factor, and thymosin-α1 in advanced metastatic solid tumors: a multicenter Phase II clinical trial ↗ PD-1 inhibitor combined with SBRT, GM-CSF, and thymosin alpha-1 in metastatic breast cancer: A case report and literature review ↗ All linked publications →